Next week: 'Personalized opportunities for microbiome optimization'

Next-week-Personalized-opportunities-for-microbiome-optimization.jpg

The FREE webinar will explore the state of the science, the established products in the marketplace, and the regulatory landscape surrounding the opportunities and challenges of the personalized microbiome category.

Personalized opportunities for microbiome optimization will take place on Tuesday, December 8 at 11:30am Eastern/ 8:30am Pacific.

Everyone’s microbiome is as unique as their own fingerprints, so it seems logical that we could have personalized interventions - prebiotics, probiotics, postbiotics, etc - tailored for the individual.

How is the market approaching this currently? What does the science say about personalized probiotics and prebiotics? Are enough consumers willing to pay for this knowledge? Which demographics are the early adopters of this (the athletic community?)? What’s next for this fascinating category?

In this webinar, NutraIngredients-USA has assembled a panel of experts to address these questions and more, and explore the latest advances in how prebiotics and probiotics are opening up commercial opportunities for personalized microbiome products.

Attendees will also have the opportunity to ask a burning question about this topic in advance by submitting the question when they register. For more information and to register, please click HERE.

Our expert speakers include:

Naveen Jain, Founder, Viome

Mariëtte Abrahams, PhD, CEO & Founder, Qina

Jim Kaput, PhD, Chief Scientific Officer and Cofounder, Vydiant Inc (ex-FDA and Nestlé)

Marc Brush, Principal, Bend LLC

The event is sponsored by:

Atlantia Food Clinical Trials: A world class company that performs acute, observational and intervention studies to ICH-GCP standards for the functional foods and beverages, supplements, pre- and probiotics and microbiome-based therapeutics sectors. 

ADM: Leaders in the scale-up and industrial manufacturing of probiotics, developing novel, proprietary and tailored strains for skin health, gastrointestinal health, immune health, oral health, and more every year that go through extensive preclinical and initial clinical evaluation.

LactoSpore: Sabinsa’s shelf-stable probiotic Bacillus coagulans MTCC 5856 is known worldwide as LactoSpore. The health benefits and stability of LactoSpore have been published in multiple peer-reviewed journals.

Probi: An international company focused exclusively on developing, producing, and delivering clinically proven probiotics. The company are experts at managing stable, live bacteria from R&D through every stage of the manufacturing process, and into finished products, including bulk formats, supplements, and functional foods.